These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 15280438

  • 1. Rotenone induces apoptosis via activation of bad in human dopaminergic SH-SY5Y cells.
    Watabe M, Nakaki T.
    J Pharmacol Exp Ther; 2004 Dec; 311(3):948-53. PubMed ID: 15280438
    [Abstract] [Full Text] [Related]

  • 2. Wild-type alpha-synuclein interacts with pro-apoptotic proteins PKCdelta and BAD to protect dopaminergic neuronal cells against MPP+-induced apoptotic cell death.
    Kaul S, Anantharam V, Kanthasamy A, Kanthasamy AG.
    Brain Res Mol Brain Res; 2005 Sep 13; 139(1):137-52. PubMed ID: 15978696
    [Abstract] [Full Text] [Related]

  • 3. [Overexpression of alpha-synuclein in SH-SY5Y cells partially protected against oxidative stress induced by rotenone].
    Liu YY, Zhao HY, Zhao CL, Duan CL, Lu LL, Yang H.
    Sheng Li Xue Bao; 2006 Oct 25; 58(5):421-8. PubMed ID: 17041725
    [Abstract] [Full Text] [Related]

  • 4. Neuroprotective effect of the antiparkinsonian drug pramipexole against nigrostriatal dopaminergic degeneration in rotenone-treated mice.
    Inden M, Kitamura Y, Tamaki A, Yanagida T, Shibaike T, Yamamoto A, Takata K, Yasui H, Taira T, Ariga H, Taniguchi T.
    Neurochem Int; 2009 Dec 25; 55(8):760-7. PubMed ID: 19647776
    [Abstract] [Full Text] [Related]

  • 5. Rotenone induces aggregation of gamma-tubulin protein and subsequent disorganization of the centrosome: relevance to formation of inclusion bodies and neurodegeneration.
    Diaz-Corrales FJ, Asanuma M, Miyazaki I, Miyoshi K, Ogawa N.
    Neuroscience; 2005 Dec 25; 133(1):117-35. PubMed ID: 15893636
    [Abstract] [Full Text] [Related]

  • 6. 1-Benzyl-1,2,3,4-tetrahydroisoquinoline, a Parkinsonism-inducing endogenous toxin, increases alpha-synuclein expression and causes nuclear damage in human dopaminergic cells.
    Shavali S, Carlson EC, Swinscoe JC, Ebadi M.
    J Neurosci Res; 2004 May 15; 76(4):563-71. PubMed ID: 15114628
    [Abstract] [Full Text] [Related]

  • 7. Oleic acid causes apoptosis and dephosphorylates Bad.
    Zhu Y, Schwarz S, Ahlemeyer B, Grzeschik S, Klumpp S, Krieglstein J.
    Neurochem Int; 2005 Jan 15; 46(2):127-35. PubMed ID: 15627513
    [Abstract] [Full Text] [Related]

  • 8. Overexpression of alpha-synuclein in rat substantia nigra results in loss of dopaminergic neurons, phosphorylation of alpha-synuclein and activation of caspase-9: resemblance to pathogenetic changes in Parkinson's disease.
    Yamada M, Iwatsubo T, Mizuno Y, Mochizuki H.
    J Neurochem; 2004 Oct 15; 91(2):451-61. PubMed ID: 15447678
    [Abstract] [Full Text] [Related]

  • 9. Possible involvement of Ca2+ signaling in rotenone-induced apoptosis in human neuroblastoma SH-SY5Y cells.
    Wang XJ, Xu JX.
    Neurosci Lett; 2005 Mar 11; 376(2):127-32. PubMed ID: 15698934
    [Abstract] [Full Text] [Related]

  • 10. Dopamine induces autophagic cell death and alpha-synuclein increase in human neuroblastoma SH-SY5Y cells.
    Gómez-Santos C, Ferrer I, Santidrián AF, Barrachina M, Gil J, Ambrosio S.
    J Neurosci Res; 2003 Aug 01; 73(3):341-50. PubMed ID: 12868068
    [Abstract] [Full Text] [Related]

  • 11. Phosphatidylinositol 3-kinase (PI-3K)/Akt but not PI-3K/p70 S6 kinase signaling mediates IGF-1-promoted lens epithelial cell survival.
    Chandrasekher G, Sailaja D.
    Invest Ophthalmol Vis Sci; 2004 Oct 01; 45(10):3577-88. PubMed ID: 15452065
    [Abstract] [Full Text] [Related]

  • 12. Dieldrin induces ubiquitin-proteasome dysfunction in alpha-synuclein overexpressing dopaminergic neuronal cells and enhances susceptibility to apoptotic cell death.
    Sun F, Anantharam V, Latchoumycandane C, Kanthasamy A, Kanthasamy AG.
    J Pharmacol Exp Ther; 2005 Oct 01; 315(1):69-79. PubMed ID: 15987830
    [Abstract] [Full Text] [Related]

  • 13. Differential cytotoxicity of human wild type and mutant alpha-synuclein in human neuroblastoma SH-SY5Y cells in the presence of dopamine.
    Moussa CE, Wersinger C, Tomita Y, Sidhu A.
    Biochemistry; 2004 May 11; 43(18):5539-50. PubMed ID: 15122920
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Dopamine facilitates alpha-synuclein oligomerization in human neuroblastoma SH-SY5Y cells.
    Yamakawa K, Izumi Y, Takeuchi H, Yamamoto N, Kume T, Akaike A, Takahashi R, Shimohama S, Sawada H.
    Biochem Biophys Res Commun; 2010 Jan 01; 391(1):129-34. PubMed ID: 19900407
    [Abstract] [Full Text] [Related]

  • 18. Induction of C/EBP beta and GADD153 expression by dopamine in human neuroblastoma cells. Relationship with alpha-synuclein increase and cell damage.
    Gómez-Santos C, Barrachina M, Giménez-Xavier P, Dalfó E, Ferrer I, Ambrosio S.
    Brain Res Bull; 2005 Feb 15; 65(1):87-95. PubMed ID: 15680548
    [Abstract] [Full Text] [Related]

  • 19. Mitochondrial complex I inhibitor rotenone inhibits and redistributes vesicular monoamine transporter 2 via nitration in human dopaminergic SH-SY5Y cells.
    Watabe M, Nakaki T.
    Mol Pharmacol; 2008 Oct 15; 74(4):933-40. PubMed ID: 18599602
    [Abstract] [Full Text] [Related]

  • 20. D2/D3 receptor agonist ropinirole protects dopaminergic cell line against rotenone-induced apoptosis through inhibition of caspase- and JNK-dependent pathways.
    Chen S, Zhang X, Yang D, Du Y, Li L, Li X, Ming M, Le W.
    FEBS Lett; 2008 Mar 05; 582(5):603-10. PubMed ID: 18242171
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.